Description
Tofacent 5 mg is a prescription disease-modifying antirheumatic drug (DMARD) containing tofacitinib. It treats moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis by inhibiting Janus kinase (JAK) enzymes to suppress immune overactivity and reduce joint or intestinal inflammation.
Key Details
- How It Works: Blocks the JAK-STAT pathway inside cells, reducing the inflammatory chemicals that cause pain, swelling, and joint stiffness.
- Standard Dosage:
- Arthritis: Typically 5 mg taken orally twice daily.
- Ulcerative Colitis: Often starts at 10 mg twice daily for 8 weeks, followed by a maintenance dose of 5 mg twice dail
Reviews
There are no reviews yet.